NCT06562439

Brief Summary

Sickle cell disease affects 100,000 people and 2,000 newborns each year; 50% of these children have a developmental deficit (\>2 SD) before the age of 3. Early identification of developmental deficit supports timely intervention, but children with sickle cell disease are grossly underdiagnosed and undertreated. The goal of the proposed study is to determine the incidence and severity of developmental deficit at 9, 18 and 30 months of age among children with sickle cell disease and test a 12-month, home-based caregiver intervention with this disproportionately affected population.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
27mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jan 2025Jul 2028

First Submitted

Initial submission to the registry

August 13, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 20, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2028

Last Updated

August 23, 2024

Status Verified

August 1, 2024

Enrollment Period

3.1 years

First QC Date

August 13, 2024

Last Update Submit

August 21, 2024

Conditions

Keywords

child developmentdevelopmental delayparents as teachershome based intervention

Outcome Measures

Primary Outcomes (4)

  • Bayley Scales of Infant Toddler Development-IV

    Child participants will complete up to 3 developmental evaluations with a trained evaluator using the Bayley Scales of Infant Toddler Development-IV. The Bayley assesses development in the domains of cognition, fine and gross motor, and expressive and receptive language. Caregiver questionnaires assess adaptive behavior and social emotional development. Scaled scores range from 1-19, where a score of 10 is average and a higher score indicates better outcome.

    Completed at 9, 18 and 30 months

  • Ages and Stages Questionnaire-3

    Caregivers will complete the Ages and Stages Questionnaire-3, which assesses the caregivers perspective of how their child is meeting developmental milestones in the domains of communication, gross motor, fine motor, personal-social and problem solving. Scores range from 0-60, where a higher score indicates a better outcome.

    Completed at 9, 18 and 30 months

  • Infant Toddler Activity Card Sort

    Caregivers will complete the Infant Toddler Activity Card Sort (ITACS) to determine activities and routines that are presenting performance or participation challenges for families in the context of their everyday lives.

    Completed at 9, 18 and 30 months

  • Behavior Rating Inventory of Executive Function-Preschool

    The Behavior Rating Inventory of Executive Function-Preschool (BRIEF) evaluates executive functioning of toddlers \>2.5 years. Executive functioning is identified as a high risk domain for deficits among individuals with sickle cell disease. Raw scores are converted to t-scores (mean = 50, SD = 10) and scores above 65 are considered clinically significant.

    30 months of age

Secondary Outcomes (3)

  • PROMIS Depression (Caregiver)

    Completed at child's 9, 18 and 30 month evaluation.

  • Acceptability

    through study completion, an average of 1 year

  • Fidelity

    through study completion, an average of 1 year

Study Arms (2)

Developmental Screening

NO INTERVENTION

Participants in this group will complete developmental screening at 9, 18, and 30 months of age.

Developmental Screening + Home-Based Intervention

EXPERIMENTAL

Participants in this group will complete developmental screening at 9, 18 and 30 months of age and monthly home visits with the family using the Parents as Teachers curriculum.

Behavioral: Sickle Cell Collaboration for Child Development

Interventions

The Sickle Cell Collaboration for Child Development (SCCCD) combines the Parents as Teachers curriculum with experienced occupational therapy to help families and children meet their learning and developmental goals.

Developmental Screening + Home-Based Intervention

Eligibility Criteria

Age6 Months - 31 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • All sickle cell disease genotypes will be included. Children will be eligible to participate until they reach 31 months of age (1 month over target evaluation).

You may not qualify if:

  • Children will be excluded if the child has fragile health, a diagnosis associated with developmental deficit (not sickle cell disease), or the family is not English language proficient -because of limitations in alternative language assessment and intervention delivery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University School of Medicine

St Louis, Missouri, 63108, United States

Location

Related Publications (70)

  • Brownson RC, Proctor EK, Luke DA, Baumann AA, Staub M, Brown MT, Johnson M. Building capacity for dissemination and implementation research: one university's experience. Implement Sci. 2017 Aug 16;12(1):104. doi: 10.1186/s13012-017-0634-4.

    PMID: 28814328BACKGROUND
  • Campbell FA, Ramey CT. Effects of early intervention on intellectual and academic achievement: a follow-up study of children from low-income families. Child Dev. 1994 Apr;65(2 Spec No):684-98.

    PMID: 8013248BACKGROUND
  • Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov;15(9):1277-88. doi: 10.1177/1049732305276687.

    PMID: 16204405BACKGROUND
  • Sandelowski M. Whatever happened to qualitative description? Res Nurs Health. 2000 Aug;23(4):334-40. doi: 10.1002/1098-240x(200008)23:43.0.co;2-g.

    PMID: 10940958BACKGROUND
  • Hennink M, Kaiser BN. Sample sizes for saturation in qualitative research: A systematic review of empirical tests. Soc Sci Med. 2022 Jan;292:114523. doi: 10.1016/j.socscimed.2021.114523. Epub 2021 Nov 2.

    PMID: 34785096BACKGROUND
  • Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 7;4:50. doi: 10.1186/1748-5908-4-50.

    PMID: 19664226BACKGROUND
  • Nilsen P, Bernhardsson S. Context matters in implementation science: a scoping review of determinant frameworks that describe contextual determinants for implementation outcomes. BMC Health Serv Res. 2019 Mar 25;19(1):189. doi: 10.1186/s12913-019-4015-3.

    PMID: 30909897BACKGROUND
  • Toomey E, Hardeman W, Hankonen N, Byrne M, McSharry J, Matvienko-Sikar K, Lorencatto F. Focusing on fidelity: narrative review and recommendations for improving intervention fidelity within trials of health behaviour change interventions. Health Psychol Behav Med. 2020 Mar 12;8(1):132-151. doi: 10.1080/21642850.2020.1738935.

    PMID: 34040865BACKGROUND
  • Nelson MC, Cordray DS, Hulleman CS, Darrow CL, Sommer EC. A procedure for assessing intervention fidelity in experiments testing educational and behavioral interventions. J Behav Health Serv Res. 2012 Oct;39(4):374-96. doi: 10.1007/s11414-012-9295-x.

    PMID: 22935907BACKGROUND
  • Gearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011 Feb;31(1):79-88. doi: 10.1016/j.cpr.2010.09.007. Epub 2010 Oct 7.

    PMID: 21130938BACKGROUND
  • Pilkonis PA, Yu L, Dodds NE, Johnston KL, Maihoefer CC, Lawrence SM. Validation of the depression item bank from the Patient-Reported Outcomes Measurement Information System (PROMIS) in a three-month observational study. J Psychiatr Res. 2014 Sep;56:112-9. doi: 10.1016/j.jpsychires.2014.05.010. Epub 2014 May 29.

    PMID: 24931848BACKGROUND
  • Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.

    PMID: 18929686BACKGROUND
  • Pilkonis PA, Choi SW, Reise SP, Stover AM, Riley WT, Cella D; PROMIS Cooperative Group. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger. Assessment. 2011 Sep;18(3):263-83. doi: 10.1177/1073191111411667. Epub 2011 Jun 21.

    PMID: 21697139BACKGROUND
  • Hoyt CR, L'Hotta AJ, Bauer AH, Chang CH, Varughese TE, Abel RA, King AA. Activity competence among infants and toddlers with developmental disabilities: Rasch analysis of the Infant Toddler Activity Card Sort (ITACS). J Patient Rep Outcomes. 2021 Jan 21;5(1):14. doi: 10.1186/s41687-021-00287-0.

    PMID: 33475869BACKGROUND
  • Schatz J, Roberts CW. Neurobehavioral impact of sickle cell disease in early childhood. J Int Neuropsychol Soc. 2007 Nov;13(6):933-43. doi: 10.1017/S1355617707071196.

    PMID: 17942011BACKGROUND
  • Rydz D, Srour M, Oskoui M, Marget N, Shiller M, Birnbaum R, Majnemer A, Shevell MI. Screening for developmental delay in the setting of a community pediatric clinic: a prospective assessment of parent-report questionnaires. Pediatrics. 2006 Oct;118(4):e1178-86. doi: 10.1542/peds.2006-0466.

    PMID: 17015506BACKGROUND
  • Radecki L, Sand-Loud N, O'Connor KG, Sharp S, Olson LM. Trends in the use of standardized tools for developmental screening in early childhood: 2002-2009. Pediatrics. 2011 Jul;128(1):14-9. doi: 10.1542/peds.2010-2180. Epub 2011 Jun 27.

    PMID: 21708798BACKGROUND
  • Hoyt CR, Chuck AC, Varughese TE, Fisher LC, Manis HE, O'Connor KE, Shen E, Wong AWK, Abel RA, King AA. Psychometric Properties of the Infant Toddler Activity Card Sort. OTJR (Thorofare N J). 2021 Oct;41(4):259-267. doi: 10.1177/15394492211012657. Epub 2021 May 6.

    PMID: 33955289BACKGROUND
  • Hoyt CR, Fernandez JD, Varughese TE, Grandgeorge E, Manis HE, O'Connor KE, Abel RA, King AA. The Infant Toddler Activity Card Sort: A Caregiver Report Measure of Children's Occupational Engagement in Family Activities and Routines. OTJR (Thorofare N J). 2020 Jan;40(1):36-41. doi: 10.1177/1539449219852030. Epub 2019 Jun 4.

    PMID: 31161868BACKGROUND
  • Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible - The Neighborhood Atlas. N Engl J Med. 2018 Jun 28;378(26):2456-2458. doi: 10.1056/NEJMp1802313. No abstract available.

    PMID: 29949490BACKGROUND
  • Heitzer AM, Cohen DL, Okhomina VI, Trpchevska A, Potter B, Longoria J, Porter JS, Estepp JH, King A, Henley M, Kang G, Hankins JS. Neurocognitive functioning in preschool children with sickle cell disease. Pediatr Blood Cancer. 2022 Mar;69(3):e29531. doi: 10.1002/pbc.29531. Epub 2021 Dec 31.

    PMID: 34971013BACKGROUND
  • Hogan AM, Pit-ten Cate IM, Vargha-Khadem F, Prengler M, Kirkham FJ. Physiological correlates of intellectual function in children with sickle cell disease: hypoxaemia, hyperaemia and brain infarction. Dev Sci. 2006 Jul;9(4):379-87. doi: 10.1111/j.1467-7687.2006.00503.x.

    PMID: 16764611BACKGROUND
  • Olds DL, Robinson J, O'Brien R, Luckey DW, Pettitt LM, Henderson CR Jr, Ng RK, Sheff KL, Korfmacher J, Hiatt S, Talmi A. Home visiting by paraprofessionals and by nurses: a randomized, controlled trial. Pediatrics. 2002 Sep;110(3):486-96. doi: 10.1542/peds.110.3.486.

    PMID: 12205249BACKGROUND
  • Olds DL, Sadler L, Kitzman H. Programs for parents of infants and toddlers: recent evidence from randomized trials. J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):355-91. doi: 10.1111/j.1469-7610.2006.01702.x.

    PMID: 17355402BACKGROUND
  • Wagner MM, Clayton SL. The Parents as Teachers program: results from two demonstrations. Future Child. 1999 Spring-Summer;9(1):91-115, 179-89.

    PMID: 10414012BACKGROUND
  • Bann CM, Wallander JL, Do B, Thorsten V, Pasha O, Biasini FJ, Bellad R, Goudar S, Chomba E, McClure E, Carlo WA. Home-Based Early Intervention and the Influence of Family Resources on Cognitive Development. Pediatrics. 2016 Apr;137(4):e20153766. doi: 10.1542/peds.2015-3766. Epub 2016 Mar 14.

    PMID: 26977079BACKGROUND
  • Neuhauser A, Ramseier E, Schaub S, Burkhardt SCA, Lanfranchi A. MEDIATING ROLE OF MATERNAL SENSITIVITY: ENHANCING LANGUAGE DEVELOPMENT IN AT-RISK FAMILIES. Infant Ment Health J. 2018 Sep;39(5):522-536. doi: 10.1002/imhj.21738. Epub 2018 Aug 8.

    PMID: 30088285BACKGROUND
  • Chaiyachati BH, Gaither JR, Hughes M, Foley-Schain K, Leventhal JM. Preventing child maltreatment: Examination of an established statewide home-visiting program. Child Abuse Negl. 2018 May;79:476-484. doi: 10.1016/j.chiabu.2018.02.019. Epub 2018 Mar 20.

    PMID: 29558714BACKGROUND
  • Yarboi J, Prussien KV, Bemis H, Williams E, Watson KH, McNally C, Henry L, King AA, DeBaun MR, Compas BE. Responsive Parenting Behaviors and Cognitive Function in Children With Sickle Cell Disease. J Pediatr Psychol. 2019 Nov 1;44(10):1234-1243. doi: 10.1093/jpepsy/jsz065.

    PMID: 31579920BACKGROUND
  • Thompson RJ Jr, Gustafson KE, Bonner MJ, Ware RE. Neurocognitive development of young children with sickle cell disease through three years of age. J Pediatr Psychol. 2002 Apr-May;27(3):235-44. doi: 10.1093/jpepsy/27.3.235.

    PMID: 11909931BACKGROUND
  • Varughese TE, Hoyt CR, L'Hotta AJ, Ikemenogo PA, Howdeshell SG, Housten AJ, Abel RA, King AA. Stress and the Home Environment in Caregivers of Children with Sickle Cell. J Pediatr Psychol. 2020 Jun 1;45(5):521-529. doi: 10.1093/jpepsy/jsaa016.

    PMID: 32232470BACKGROUND
  • Committee on Children With Disabilities. Role of the pediatrician in family-centered early intervention services. Pediatrics. 2001 May;107(5):1155-7. doi: 10.1542/peds.107.5.1155.

    PMID: 11331701BACKGROUND
  • Gallegos A, Dudovitz R, Biely C, Chung PJ, Coker TR, Barnert E, Guerrero AD, Szilagyi PG, Nelson BB. Racial Disparities in Developmental Delay Diagnosis and Services Received in Early Childhood. Acad Pediatr. 2021 Sep-Oct;21(7):1230-1238. doi: 10.1016/j.acap.2021.05.008. Epub 2021 May 19.

    PMID: 34020100BACKGROUND
  • Shook LM, Farrell CB, Kalinyak KA, Nelson SC, Hardesty BM, Rampersad AG, Saving KL, Whitten-Shurney WJ, Panepinto JA, Ware RE, Crosby LE. Translating sickle cell guidelines into practice for primary care providers with Project ECHO. Med Educ Online. 2016 Nov 24;21:33616. doi: 10.3402/meo.v21.33616. eCollection 2016.

    PMID: 27887664BACKGROUND
  • Whiteman LN, Haywood C Jr, Lanzkron S, Strouse JJ, Feldman L, Stewart RW. Primary Care Providers' Comfort Levels in Caring for Patients with Sickle Cell Disease. South Med J. 2015 Sep;108(9):531-6. doi: 10.14423/SMJ.0000000000000331.

    PMID: 26332477BACKGROUND
  • Lipkin PH, Macias MM, Baer Chen B, Coury D, Gottschlich EA, Hyman SL, Sisk B, Wolfe A, Levy SE. Trends in Pediatricians' Developmental Screening: 2002-2016. Pediatrics. 2020 Apr;145(4):e20190851. doi: 10.1542/peds.2019-0851. Epub 2020 Mar 2.

    PMID: 32123018BACKGROUND
  • Armstrong FD, Elkin TD, Brown RC, Glass P, Rana S, Casella JF, Kalpatthi RV, Pavlakis S, Mi Z, Wang WC; Baby Hug Investigators. Developmental function in toddlers with sickle cell anemia. Pediatrics. 2013 Feb;131(2):e406-14. doi: 10.1542/peds.2012-0283. Epub 2013 Jan 6.

    PMID: 23296434BACKGROUND
  • Drazen CH, Abel R, Gabir M, Farmer G, King AA. Prevalence of Developmental Delay and Contributing Factors Among Children With Sickle Cell Disease. Pediatr Blood Cancer. 2016 Mar;63(3):504-10. doi: 10.1002/pbc.25838. Epub 2015 Nov 17.

    PMID: 26575319BACKGROUND
  • Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517.

    PMID: 25203083BACKGROUND
  • Wang WC, Zou P, Hwang SN, Kang G, Ding J, Heitzer AM, Schreiber JE, Helton K, Hankins JS. Effects of hydroxyurea on brain function in children with sickle cell anemia. Pediatr Blood Cancer. 2021 Oct;68(10):e29254. doi: 10.1002/pbc.29254. Epub 2021 Jul 31.

    PMID: 34331507BACKGROUND
  • Miller M, Landsman R, Scott JP, Heffelfinger AK. Fostering equity in education and academic outcomes in children with sickle cell disease. Clin Neuropsychol. 2022 Feb;36(2):245-263. doi: 10.1080/13854046.2021.1945147. Epub 2021 Jul 5.

    PMID: 34218732BACKGROUND
  • Burnes DP, Antle BJ, Williams CC, Cook L. Mothers raising children with sickle cell disease at the intersection of race, gender, and illness stigma. Health Soc Work. 2008 Aug;33(3):211-20. doi: 10.1093/hsw/33.3.211.

    PMID: 18773796BACKGROUND
  • Nelson SC, Hackman HW. Race matters: perceptions of race and racism in a sickle cell center. Pediatr Blood Cancer. 2013 Mar;60(3):451-4. doi: 10.1002/pbc.24361. Epub 2012 Sep 28.

    PMID: 23023789BACKGROUND
  • Constantino JN, Abbacchi AM, Saulnier C, Klaiman C, Mandell DS, Zhang Y, Hawks Z, Bates J, Klin A, Shattuck P, Molholm S, Fitzgerald R, Roux A, Lowe JK, Geschwind DH. Timing of the Diagnosis of Autism in African American Children. Pediatrics. 2020 Sep;146(3):e20193629. doi: 10.1542/peds.2019-3629.

    PMID: 32839243BACKGROUND
  • Schatz J, Schlenz AM, Smith KE, Roberts CW. Predictive validity of developmental screening in young children with sickle cell disease: a longitudinal follow-up study. Dev Med Child Neurol. 2018 May;60(5):520-526. doi: 10.1111/dmcn.13689. Epub 2018 Feb 28.

    PMID: 29488622BACKGROUND
  • Schatz J, McClellan CB, Puffer ES, Johnson K, Roberts CW. Neurodevelopmental screening in toddlers and early preschoolers with sickle cell disease. J Child Neurol. 2008 Jan;23(1):44-50. doi: 10.1177/0883073807307982. Epub 2007 Dec 26.

    PMID: 18160556BACKGROUND
  • Hogan AM, Kirkham FJ, Prengler M, Telfer P, Lane R, Vargha-Khadem F, Haan M. An exploratory study of physiological correlates of neurodevelopmental delay in infants with sickle cell anaemia. Br J Haematol. 2006 Jan;132(1):99-107. doi: 10.1111/j.1365-2141.2005.05828.x.

    PMID: 16371025BACKGROUND
  • Kawadler JM, Clayden JD, Clark CA, Kirkham FJ. Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis. Dev Med Child Neurol. 2016 Jul;58(7):672-9. doi: 10.1111/dmcn.13113. Epub 2016 Mar 31.

    PMID: 27038278BACKGROUND
  • Prussien KV, Jordan LC, DeBaun MR, Compas BE. Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis. J Pediatr Psychol. 2019 Sep 1;44(8):948-958. doi: 10.1093/jpepsy/jsz031.

    PMID: 31050352BACKGROUND
  • Damschroder LJ, Reardon CM, Opra Widerquist MA, Lowery J. Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR Outcomes Addendum. Implement Sci. 2022 Jan 22;17(1):7. doi: 10.1186/s13012-021-01181-5.

    PMID: 35065675BACKGROUND
  • Davis M, Beidas RS. Refining contextual inquiry to maximize generalizability and accelerate the implementation process. Implement Res Pract. 2021 Mar 17;2:2633489521994941. doi: 10.1177/2633489521994941. eCollection 2021 Jan-Dec.

    PMID: 37089986BACKGROUND
  • Council on Children With Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics. 2006 Jul;118(1):405-20. doi: 10.1542/peds.2006-1231.

    PMID: 16818591BACKGROUND
  • DeBaun MR, Jordan LC, King AA, Schatz J, Vichinsky E, Fox CK, McKinstry RC, Telfer P, Kraut MA, Daraz L, Kirkham FJ, Murad MH. American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Adv. 2020 Apr 28;4(8):1554-1588. doi: 10.1182/bloodadvances.2019001142.

    PMID: 32298430BACKGROUND
  • Proctor EK, Powell BJ, McMillen JC. Implementation strategies: recommendations for specifying and reporting. Implement Sci. 2013 Dec 1;8:139. doi: 10.1186/1748-5908-8-139.

    PMID: 24289295BACKGROUND
  • Hoyt Drazen C, Abel R, Lindsey T, King AA. Development and feasibility of a home-based education model for families of children with sickle cell disease. BMC Public Health. 2014 Feb 5;14:116. doi: 10.1186/1471-2458-14-116.

    PMID: 24499305BACKGROUND
  • Peacock S, Konrad S, Watson E, Nickel D, Muhajarine N. Effectiveness of home visiting programs on child outcomes: a systematic review. BMC Public Health. 2013 Jan 9;13:17. doi: 10.1186/1471-2458-13-17.

    PMID: 23302300BACKGROUND
  • King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR. Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. Am J Hematol. 2014 Oct;89(10):E188-92. doi: 10.1002/ajh.23805. Epub 2014 Aug 4.

    PMID: 25042018BACKGROUND
  • Yarboi J, Compas BE, Brody GH, White D, Rees Patterson J, Ziara K, King A. Association of social-environmental factors with cognitive function in children with sickle cell disease. Child Neuropsychol. 2017 Apr;23(3):343-360. doi: 10.1080/09297049.2015.1111318. Epub 2015 Nov 15.

    PMID: 26568287BACKGROUND
  • Hoyt CR, Varughese TE, Erickson J, Haffner N, Luo L, L'Hotta AJ, Yeager L, King AA. Developmental delay in infants and toddlers with sickle cell disease: a systematic review. Dev Med Child Neurol. 2022 Feb;64(2):168-175. doi: 10.1111/dmcn.15048. Epub 2021 Sep 17.

    PMID: 34535892BACKGROUND
  • Fields ME, Hoyt-Drazen C, Abel R, Rodeghier MJ, Yarboi JM, Compas BE, King AA. A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease. Pediatr Blood Cancer. 2016 Dec;63(12):2131-2138. doi: 10.1002/pbc.26164. Epub 2016 Aug 11.

    PMID: 27509845BACKGROUND
  • Varni JW, Panepinto JA. Cognitive functioning, patient health communication, and worry mediate pain predictive effects on health-related quality of life in youth with sickle cell disease. Pediatr Blood Cancer. 2020 Nov;67(11):e28680. doi: 10.1002/pbc.28680. Epub 2020 Aug 29.

    PMID: 32860648BACKGROUND
  • Hardy SJ, Bills SE, Wise SM, Hardy KK. Cognitive Abilities Moderate the Effect of Disease Severity on Health-Related Quality of Life in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2018 Sep 1;43(8):882-894. doi: 10.1093/jpepsy/jsy019.

    PMID: 29659914BACKGROUND
  • Barakat LP, Patterson CA, Daniel LC, Dampier C. Quality of life among adolescents with sickle cell disease: mediation of pain by internalizing symptoms and parenting stress. Health Qual Life Outcomes. 2008 Aug 9;6:60. doi: 10.1186/1477-7525-6-60.

    PMID: 18691422BACKGROUND
  • Sanger M, Jordan L, Pruthi S, Day M, Covert B, Merriweather B, Rodeghier M, DeBaun M, Kassim A. Cognitive deficits are associated with unemployment in adults with sickle cell anemia. J Clin Exp Neuropsychol. 2016 Aug;38(6):661-71. doi: 10.1080/13803395.2016.1149153.

    PMID: 27167865BACKGROUND
  • Aygun B, Parker J, Freeman MB, Stephens AL, Smeltzer MP, Wu S, Hankins JS, Wang WC. Neurocognitive screening with the Brigance preschool screen-II in 3-year-old children with sickle cell disease. Pediatr Blood Cancer. 2011 Apr;56(4):620-4. doi: 10.1002/pbc.22833. Epub 2010 Nov 11.

    PMID: 21298749BACKGROUND
  • Farber MD, Koshy M, Kinney TR. Cooperative Study of Sickle Cell Disease: Demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis. 1985;38(6):495-505. doi: 10.1016/0021-9681(85)90033-5.

    PMID: 4008590BACKGROUND
  • Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010 Dec 11;376(9757):2018-31. doi: 10.1016/S0140-6736(10)61029-X. Epub 2010 Dec 3.

    PMID: 21131035BACKGROUND
  • Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998 Jan 1;91(1):288-94.

    PMID: 9414296BACKGROUND
  • Piel FB, Steinberg MH, Rees DC. Sickle Cell Disease. N Engl J Med. 2017 Apr 20;376(16):1561-1573. doi: 10.1056/NEJMra1510865. No abstract available.

    PMID: 28423290BACKGROUND
  • Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010 Apr;38(4 Suppl):S512-21. doi: 10.1016/j.amepre.2009.12.022.

    PMID: 20331952BACKGROUND

MeSH Terms

Conditions

Anemia, Sickle CellLearning Disabilities

Interventions

Child Development

Condition Hierarchy (Ancestors)

Anemia, Hemolytic, CongenitalAnemia, HemolyticAnemiaHematologic DiseasesHemic and Lymphatic DiseasesHemoglobinopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Human DevelopmentGrowth and DevelopmentPhysiological Phenomena

Central Study Contacts

Catherine R Hoyt, PhD

CONTACT

Tiffany Radar

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Model Details: We will randomize children to receive developmental screening alone or developmental screening with a home-based intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 13, 2024

First Posted

August 20, 2024

Study Start

January 1, 2025

Primary Completion (Estimated)

January 31, 2028

Study Completion (Estimated)

July 31, 2028

Last Updated

August 23, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Findings from this proposal will be disseminated in peer-reviewed publications and at scholarly meetings following best practices guidelines (e.g., Equator network guidelines).

Locations